These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2617981

  • 41. Mesangiocapillary glomerulonephritis.
    D'Amico G, Ferrario F.
    J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S159-66. PubMed ID: 1534701
    [Abstract] [Full Text] [Related]

  • 42. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
    Ikezumi Y, Suzuki T, Hayafuji S, Okubo S, Nikolic-Paterson DJ, Kawachi H, Shimizu F, Uchiyama M.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
    [Abstract] [Full Text] [Related]

  • 43. Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome.
    Banfi G, Mazzucco G, Barbiano di Belgiojoso G, Bestetti Bosisio M, Stratta P, Confalonieri R, Ferrario F, Imbasciati E, Monga G.
    Q J Med; 1985 May; 55(217):153-68. PubMed ID: 3159033
    [Abstract] [Full Text] [Related]

  • 44. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
    Iitaka K, Yamamoto A, Ogawa N, Sekine T, Tamai S, Motoyama O.
    Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
    [Abstract] [Full Text] [Related]

  • 45. Severe primary IgA glomerulonephritis.
    Bodaghi E, Vazirian C, Madani A, Honarmand MT, Elmi F.
    Child Nephrol Urol; 2003 Dec; 9(1-2):84-6. PubMed ID: 3251628
    [Abstract] [Full Text] [Related]

  • 46. Cirrhotic glomerulonephritis: an underdiagnosed condition.
    Ori Y, Korzets A, Sandbank J, Lurie B, Zeidman A, Gafter U.
    Isr J Med Sci; 1996 Dec; 32(12):1222-4. PubMed ID: 9007158
    [Abstract] [Full Text] [Related]

  • 47. [Diffuse mesangial proliferative glomerulonephritis].
    Riabov SI, Klemina IK, Plotkin VIa.
    Klin Med (Mosk); 1982 Jun; 60(6):86-92. PubMed ID: 7120896
    [No Abstract] [Full Text] [Related]

  • 48. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S, Kuriyama H, Iino N, Iguchi S, Shimada H, Ueno M, Narita I, Nakano M, Nishi S, Karasawa R, Gejyo F.
    Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
    Taguchi T, Bohle A.
    Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
    [Abstract] [Full Text] [Related]

  • 50. [Sclerotic changes in the glomeruli in glomerulonephritis in children (immunohistochemical study].
    Shekhonin BV, Gozalishvili TV, Varshavskiĭ VA.
    Arkh Patol; 1995 Jun; 57(3):57-61. PubMed ID: 7677584
    [Abstract] [Full Text] [Related]

  • 51. The consequences for renal function of the glomerular deposition of PAS positive material in proliferative glomerulopathies. A quantitative study.
    Danilewicz M, Wagrowska-Danilewicz M.
    Gen Diagn Pathol; 1997 Dec; 143(4):225-30. PubMed ID: 9489955
    [Abstract] [Full Text] [Related]

  • 52. Structural-functional relationships in type I mesangiocapillary glomerulonephritis.
    Hattori M, Kim Y, Steffes MW, Mauer SM.
    Kidney Int; 1993 Feb; 43(2):381-6. PubMed ID: 8441233
    [Abstract] [Full Text] [Related]

  • 53. Mesangiocapillary glomerulonephritis in Down's syndrome.
    Gupta SK, Venkataseshan VS, Churg J.
    Am J Nephrol; 1991 Feb; 11(2):112-7. PubMed ID: 1835296
    [Abstract] [Full Text] [Related]

  • 54. Differences between type I and II membranoproliferative glomerulonephritis.
    Andresdottir MB, Wetzels J.
    Kidney Int; 2006 Oct; 70(8):1526-7; author reply 1527. PubMed ID: 17024173
    [No Abstract] [Full Text] [Related]

  • 55. Fat cell loss and mesangiocapillary glomerulonephritis: chicken, egg or both?
    Mathieson PW, Peters DK.
    Nephron Clin Pract; 2004 Oct; 96(2):c33-4. PubMed ID: 14988594
    [No Abstract] [Full Text] [Related]

  • 56. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.
    Duvall-Young J, MacDonald MK, McKechnie NM.
    Br J Ophthalmol; 1989 Apr; 73(4):297-302. PubMed ID: 2713310
    [Abstract] [Full Text] [Related]

  • 57. Fundus changes in mesangiocapillary glomerulonephritis.
    Beaumont P.
    Br J Ophthalmol; 1989 Nov; 73(11):932. PubMed ID: 2605151
    [No Abstract] [Full Text] [Related]

  • 58. Mesangiocapillary glomerulonephritis associated with ulcerative colitis: a 6-year follow-up of 2 cases.
    Ashman N, Sheaff M, Raftery MJ.
    Clin Nephrol; 2003 Aug; 60(2):146-8. PubMed ID: 12940620
    [No Abstract] [Full Text] [Related]

  • 59. [Mesangiocapillary glomerulonephritis type II and macular degeneration].
    Asensio-Sánchez VM, Asensio-Sánchez MJ, Rodríguez-Delgado B, García-Herrero E, Cabo-Vaquera V, García-Loygorri C.
    Arch Soc Esp Oftalmol; 2007 Jan; 82(1):43-5. PubMed ID: 17262236
    [Abstract] [Full Text] [Related]

  • 60. Mesangiocapillary glomerulonephritis associated with hydatid disease.
    Rincón B, Bernis C, Garcia A, Traver JA.
    Nephrol Dial Transplant; 1993 Jan; 8(8):783-4. PubMed ID: 8414165
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.